Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect

Abstract Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with high propensity for lymphatic spread and distant metastasis. It is prominent as an endemic malignancy in Southern China and Southeast Asia regions. Studies on NPC pathogenesis mechanism in the past decades such as through Epste...

Full description

Bibliographic Details
Main Authors: Pui Yan Siak, Win Sen Heng, Sharon Siew Hoon Teoh, Yu Yu Lwin, Shiau-Chuen Cheah
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-023-04673-8
_version_ 1797629998307213312
author Pui Yan Siak
Win Sen Heng
Sharon Siew Hoon Teoh
Yu Yu Lwin
Shiau-Chuen Cheah
author_facet Pui Yan Siak
Win Sen Heng
Sharon Siew Hoon Teoh
Yu Yu Lwin
Shiau-Chuen Cheah
author_sort Pui Yan Siak
collection DOAJ
description Abstract Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with high propensity for lymphatic spread and distant metastasis. It is prominent as an endemic malignancy in Southern China and Southeast Asia regions. Studies on NPC pathogenesis mechanism in the past decades such as through Epstein Barr Virus (EBV) infection and oncogenic molecular aberrations have explored several potential targets for therapy and diagnosis. The EBV infection introduces oncoviral proteins that consequently hyperactivate many promitotic pathways and block cell-death inducers. EBV infection is so prevalent in NPC patients such that EBV serological tests were used to diagnose and screen NPC patients. On the other hand, as the downstream effectors of oncogenic mechanisms, the promitotic pathways can potentially be exploited therapeutically. With the apparent heterogeneity and distinct molecular aberrations of NPC tumor, the focus has turned into a more personalized treatment in NPC. Herein in this comprehensive review, we depict the current status of screening, diagnosis, treatment, and prevention in NPC. Subsequently, based on the limitations on those aspects, we look at their potential improvements in moving towards the path of precision medicine. The importance of recent advances on the key molecular aberration involved in pathogenesis of NPC for precision medicine progression has also been reported in the present review. Besides, the challenge and future outlook of NPC management will also be highlighted.
first_indexed 2024-03-11T11:00:47Z
format Article
id doaj.art-02874d9c59dc443db659c321a0fefa34
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-03-11T11:00:47Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-02874d9c59dc443db659c321a0fefa342023-11-12T12:28:43ZengBMCJournal of Translational Medicine1479-58762023-11-0121116010.1186/s12967-023-04673-8Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospectPui Yan Siak0Win Sen Heng1Sharon Siew Hoon Teoh2Yu Yu Lwin3Shiau-Chuen Cheah4Faculty of Medicine and Health Sciences, UCSI UniversityFaculty of Medicine and Health Sciences, UCSI UniversityFaculty of Medicine and Health Sciences, UCSI UniversityDepartment of Otorhinolaryngology-Head and Neck Surgery, University of MedicineFaculty of Medicine and Health Sciences, UCSI UniversityAbstract Nasopharyngeal carcinoma (NPC) is an aggressive malignancy with high propensity for lymphatic spread and distant metastasis. It is prominent as an endemic malignancy in Southern China and Southeast Asia regions. Studies on NPC pathogenesis mechanism in the past decades such as through Epstein Barr Virus (EBV) infection and oncogenic molecular aberrations have explored several potential targets for therapy and diagnosis. The EBV infection introduces oncoviral proteins that consequently hyperactivate many promitotic pathways and block cell-death inducers. EBV infection is so prevalent in NPC patients such that EBV serological tests were used to diagnose and screen NPC patients. On the other hand, as the downstream effectors of oncogenic mechanisms, the promitotic pathways can potentially be exploited therapeutically. With the apparent heterogeneity and distinct molecular aberrations of NPC tumor, the focus has turned into a more personalized treatment in NPC. Herein in this comprehensive review, we depict the current status of screening, diagnosis, treatment, and prevention in NPC. Subsequently, based on the limitations on those aspects, we look at their potential improvements in moving towards the path of precision medicine. The importance of recent advances on the key molecular aberration involved in pathogenesis of NPC for precision medicine progression has also been reported in the present review. Besides, the challenge and future outlook of NPC management will also be highlighted.https://doi.org/10.1186/s12967-023-04673-8Nasopharyngeal carcinomaPersonalized medicineEpstein–Barr virusCancer stem cellMetastasisMolecular heterogeneity
spellingShingle Pui Yan Siak
Win Sen Heng
Sharon Siew Hoon Teoh
Yu Yu Lwin
Shiau-Chuen Cheah
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
Journal of Translational Medicine
Nasopharyngeal carcinoma
Personalized medicine
Epstein–Barr virus
Cancer stem cell
Metastasis
Molecular heterogeneity
title Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
title_full Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
title_fullStr Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
title_full_unstemmed Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
title_short Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
title_sort precision medicine in nasopharyngeal carcinoma comprehensive review of past present and future prospect
topic Nasopharyngeal carcinoma
Personalized medicine
Epstein–Barr virus
Cancer stem cell
Metastasis
Molecular heterogeneity
url https://doi.org/10.1186/s12967-023-04673-8
work_keys_str_mv AT puiyansiak precisionmedicineinnasopharyngealcarcinomacomprehensivereviewofpastpresentandfutureprospect
AT winsenheng precisionmedicineinnasopharyngealcarcinomacomprehensivereviewofpastpresentandfutureprospect
AT sharonsiewhoonteoh precisionmedicineinnasopharyngealcarcinomacomprehensivereviewofpastpresentandfutureprospect
AT yuyulwin precisionmedicineinnasopharyngealcarcinomacomprehensivereviewofpastpresentandfutureprospect
AT shiauchuencheah precisionmedicineinnasopharyngealcarcinomacomprehensivereviewofpastpresentandfutureprospect